• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Does chronic nitrate therapy induce tolerance to short-acting ones?

作者信息

Bultas J, Karetová D

机构信息

2nd Department of Medicine, 1st Medical Faculty, Charles University, Prague, Czech Republic.

出版信息

Sb Lek. 1993;94(1):71-5.

PMID:7992001
Abstract

The aim of this study was to ascertain whether long-term nitrate administration (therapy by 120 mg ISDN or 16 mg molsidomine) decreases the efficiency of administered short-acting nitrate by the mechanism of tolerance. Fourteen male patients (mean age 56 years) with stabilized angina (IIIrd degree) were included and stress test with standard workload of 75 W was performed at the beginning of the study after cessation of therapy. Subsequently, the test was repeated after administration of 2.5 mg ISDN (IsoMack spray). The period of time until maximal load increased more than twice (4.0 +/- 1.3 vs 9.1 +2- 3.3 min. mean +/- SD). Afterward, patients were treated by ISDN 120 mg (IsoMack 120) once a day or molsidomine 8 mg (Corvaton ret.) twice a day; both drugs were interchanged after the period of 6 weeks. Stress tests were repeated at the end of these therapy periods (before and after application of short-acting nitrate). During 120 mg ISDN therapy, the time until maximal load after the application of 2.5 mg ISDN increased analogously (6.2 +/- 1.8 vs 9.6 +/- 3.7 min) and similarly after molsidomin therapy (5.5 +/- 1.7 vs 10.0 +/- 4.1 min). These results indicate that stress tolerance increases after short-acting nitrate administration significantly also in patients treated by high doses of long-acting nitrates (ISDN or molsidomine). Inducing of tolerance to short-acting nitrates was not observed.

摘要

相似文献

1
Does chronic nitrate therapy induce tolerance to short-acting ones?
Sb Lek. 1993;94(1):71-5.
2
What intervals in oral therapy of isosorbide dinitrate in various doses are sufficient to prevent nitrate tolerance?
Med Sci Monit. 2000 Jul-Aug;6(4):763-8.
3
[Development of nitrate tolerance in individual patients with stable angina pectoris in various phases of therapy with oral isosorbide dinitrate].[口服硝酸异山梨酯治疗稳定型心绞痛患者不同阶段个体硝酸酯类药物耐受性的发展]
Pol Merkur Lekarski. 2002 Jul;13(73):52-5.
4
[Evaluation of antianginal efficacy of long-term therapy with low dose isosorbide dinitrate in patients with stable angina pectoris].
Przegl Lek. 2000;57(9):455-8.
5
[Comparison of the effects of molsidomine retard and isosorbide dinitrate retard in patients with stable angina pectoris using an ergometry test].
Vnitr Lek. 1993 Sep;39(9):856-64.
6
Differences in the antiischaemic effects of molsidomine and isosorbide dinitrate (ISDN) during acute and short-term administration in stable angina pectoris.在稳定型心绞痛患者急性和短期给药期间,莫西多明与硝酸异山梨酯(ISDN)抗缺血作用的差异。
Eur Heart J. 1991 Sep;12(9):994-9. doi: 10.1093/eurheartj/12.9.994.
7
Nitrates for angina pectoris. A critical review of therapeutic efficacy and tolerance.用于治疗心绞痛的硝酸盐类药物。对治疗效果和耐受性的批判性综述。
Herz. 1984 Jun;9(3):123-36.
8
Efficacy and safety of molsidomine once-a-day in patients with stable angina pectoris.单硝酸异山梨酯每日一次给药治疗稳定型心绞痛患者的疗效与安全性。
Int J Cardiol. 2005 Jan;98(1):79-89. doi: 10.1016/j.ijcard.2004.01.007.
9
Comparative study of long-term effects of Molsidomin 8 mg (slow release form) and ISDN 40 mg (slow release form) on angina pectoris and ischaemic ST-segment depression during maximal bicycle-ergometry in patients with coronary insufficiency.
Eur Heart J. 1987 Oct;8 Suppl G:63-9. doi: 10.1093/eurheartj/8.suppl_g.63.
10
Antianginal efficacy of long-term nitrate therapy.长期硝酸盐治疗的抗心绞痛疗效。
Z Kardiol. 1983;72 Suppl 3:233-8.

引用本文的文献

1
Clinical pharmacokinetics of vasodilators. Part II.血管扩张剂的临床药代动力学。第二部分。
Clin Pharmacokinet. 1998 Jul;35(1):9-36. doi: 10.2165/00003088-199835010-00002.